Quick Answer
PTC THERAPEUTICS, INC. reported Long Term Debt of $285.41 million for the year ending 2024.
- PTC THERAPEUTICS, INC. showed an increase of +0.4% in Long Term Debt from 2023 to 2024.
- This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $93.20 million | Q1 2016: $93.37 million | Q2 2016: $94.94 million | Q3 2016: $96.56 million | Q1 2017: $99.90 million | Q2 2017: $141.24 million | Q3 2017: $143.09 million | Q1 2018: $146.88 million | Q2 2018: $147.20 million | Q3 2018: $144.26 million | Q1 2019: $138.47 million | Q2 2019: $135.68 million | Q3 2019: $293.15 million | Q1 2020: $294.57 million | Q2 2020: $297.03 million | Q3 2020: $302.97 million | Q1 2021: $430.04 million | Q2 2021: $430.50 million | Q3 2021: $281.60 million | Q1 2022: $282.18 million | Q2 2022: $282.46 million | Q3 2022: $282.75 million | Q1 2023: $572.09 million | Q2 2023: $572.64 million | Q3 2023: $573.17 million | Q1 2024: $284.51 million | Q2 2024: $284.81 million | Q3 2024: $285.11 million | Q1 2025: $285.71 million | Q2 2025: $286.01 million.
- Over the full 11 years of available data (2012 to 2024), PTC THERAPEUTICS, INC.'s Long Term Debt has grown by 64,942.3%.
- Historical annual values: Fiscal year 2024: $285.41 million | Fiscal year 2023: $284.21 million | Fiscal year 2022: $571.72 million | Fiscal year 2021: $281.89 million | Fiscal year 2020: $309.15 million | Fiscal year 2019: $293.86 million | Fiscal year 2018: $141.35 million | Fiscal year 2017: $144.97 million | Fiscal year 2016: $98.22 million | Fiscal year 2015: $91.85 million | Fiscal year 2012: $438.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: